1. Homepage
  2. Profession
  3. Publications
  4. Bulletin references
  5. Bulletin references October 2018
  6. Page 221 - Human papillomavirus vaccination: deployment, impact and future plans

Page 221 - Human papillomavirus vaccination: deployment, impact and future plans

Dr Kate Soldan and Dr Simon Beddows

References 

  1. Schiller JT, Müller M. Next generation prophylactic human papillomavirus vaccines. Lancet Oncol. 2015;16(5):e217–25.
  2. Schiller JT, Lowy DR. Understanding and learning from the success of prophylactic human papillomavirus vaccines. Nat Rev Microbiol. 2012;10(10):681–692.
  3. Human papillomavirus vaccines: WHO position paper – Recommendations. Vaccine. 2015;33(36):4383–4.
  4. Scherer EM, Smith RA, Carter JJ, Wipf GC, Gallego DF, Stern M, Wald A, Galloway DA. Analysis of Memory B-Cell Responses Reveals Suboptimal Dosing Schedule of a Licensed Vaccine. J Infect Dis. 2018;217(4):572-580.
  5. Phillips A, Patel C, Pillsbury A, Brotherton J, Macartney K. Safety of Human Papillomavirus Vaccines: An Updated Review. Drug Safety 2018; 41(4):329–346.
  6. Immunisation against infectious diseases. The Green Book. Revised 2018. Available at: www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book#the-green-book
  7. Drolet M, Benard E, Boily MC et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet InfectDis 2015; 15(5):565–580.
  8. Mesher D, Panwar K, Thomas SL, Edmundson C, Choi YH, Beddows S et al. The impact of the national HPV vaccination programme in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010–2016. J Infect Dis. 2018. doi: 10.1093/infdis/jiy249.
  9. Kavanagh K, Pollock KG, Cuschieri K et al. Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. The Lancet Infectious Diseases 2017; 17:1293–1302.
  10. Mesher D, Soldan K, Lehtinen M, Beddows S, Brisson M, Brotherton JM et al. Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes. Emerg Infect Dis. 2016;22(10):1732–1740. doi: 10.3201/eid2210.160675. Review.
  11. Malagón T, Laurie C, Franco EL. Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review. Expert Rev Vaccines. 2018;17(5):395-409.